Natural history and long-term clinical course of Crohn's disease

World Journal of Gastroenterology

Volumn 20, Issue 1, 2014, Pages 31-36

  Freeman, Hugh James ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Age dependent phenotypes; Crohn's disease; Natural history

Indexed keywords

ADULT ONSET STILL DISEASE; AGE; ARTICLE; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; ENDOSCOPIC BIOPSY; GENETIC SUSCEPTIBILITY; GRANULOMATOUS INFLAMMATION; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; PHENOTYPE; RISK FACTOR;

AGE-DEPENDENT PHENOTYPES; CROHN'S DISEASE; NATURAL HISTORY;

AGE OF ONSET; ANTI-INFLAMMATORY AGENTS; CROHN DISEASE; DISEASE PROGRESSION; GASTROINTESTINAL AGENTS; HUMANS; INTESTINES; PHENOTYPE; RECURRENCE; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84891776407     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i1.31     Document Type: Article

References (62)

1. Ventham NT, Kennedy NA, Nimmo ER, Satsangi J. Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. Gastroenterology 2013; 145: 293-308. [PMID: 23751777 DOI: 10.1053/j.gastro.2013.05.050]
2. Lees CW, Satsangi J. Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history. Expert Rev Gastroenterol Hepatol 2009; 3: 513-534. [PMID: 19817673 DOI: 10.1586/egh.09.45]
3. Henckaerts L, Van Steen K, Verstreken I, Cleynen I, Franke A, Schreiber S, Rutgeerts P, Vermeire S. Genetic risk profiling and prediction of disease course in Crohn's disease patients. Clin Gastroenterol Hepatol 2009; 7: 972-980. [PMID: 19422935 DOI: 10.1016/j.cgh.2009.05.001]
4. Beaugerie L, Sokol H. Clinical, serological and genetic predictors of inflammatory bowel disease course. World J Gastroenterol 2012; 18: 3806-3813. [PMID: 22876031 DOI: 10.3748/wjg. v18.i29.3806]
5. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-434. [PMID: 17653185 DOI: 10.1038/nature06005]
6. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54. quiz e30. [PMID: 22001864 DOI: 10.1053/j.gastro.2011.10.001]
7. Williams GT, Williams WJ. Granulomatous inflammation-a review. J Clin Pathol 1983; 36: 723-733. [PMID: 6345591 DOI: 10.1136/jcp.36.7.723]
8. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8-15. [PMID: 10701144 DOI: 10.1097/00054725-200002000-000 02]
9. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, Jewell DP, Karban A, Loftus EV, Peña AS, Riddell RH, Sachar DB, Schreiber S, Steinhart AH, Targan SR, Vermeire S, Warren BF. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 Suppl A: 5A-36A. [PMID: 16151544]
10. Freeman HJ. Application of the Vienna Classification for Crohn's disease to a single clinician database of 877 patients. Can J Gastroenterol 2001; 15: 89-93. [PMID: 11240378]
11. Freeman HJ. Application of the Montreal classification for Crohn's disease to a single clinician database of 1015 patients. Can J Gastroenterol 2007; 21: 363-366. [PMID: 17571169]
12. Nugent FW, Glaser D, Fernandez-Herlihy L. Crohn's colitis associated with granulomatous bone disease. N Engl J Med 1976; 294: 262-263. [PMID: 1244552 DOI: 10.1056/NEJM197601292940507]
13. Freeman HJ, Kwong R, Sacks SL. Granulomatous vaginal ulceration due to metastatic cutaneous Crohn's disease. Can J Gastroenterol 1995; 9: 183-186
14. Freeman HJ, Owen D, Millan M. Granulomatous osteonecrosis in Crohn's disease. Can J Gastroenterol 2000; 14: 951-954. [PMID: 11125186]
15. Freeman HJ, Maguire J. Sellar inflammatory mass with inflammatory bowel disease. Can J Gastroenterol 2010; 24: 58-60. [PMID: 20186358]
16. Freeman HJ. Long-term clinical behavior of jejunoileal involvement in Crohn's disease. Can J Gastroenterol 2005; 19: 575-578. [PMID: 16151550]
17. Freeman HJ. Familial Crohn's disease in single or multiple first-degree relatives. J Clin Gastroenterol 2002; 35: 9-13. [PMID: 12080219 DOI: 10.1097/00004836-200207000-00004]
18. Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJ, Mascheretti S, Sanderson J, Forbes A, Mansfield J, Schreiber S, Lewis CM, Mathew CG. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002; 122: 867-874. [PMID: 11910337 DOI: 10.1053/gast.2002.32415]
19. Newman B, Silverberg MS, Gu X, Zhang Q, Lazaro A, Steinhart AH, Greenberg GR, Griffiths AM, McLeod RS, Cohen Z, Fernández-Viña M, Amos CI, Siminovitch K. CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn's disease. Am J Gastroenterol 2004; 99: 306-315. [PMID: 15046222 DOI: 10.1111/j.1572-0241.2004.04038.x]
20. Chow DK, Sung JJ, Wu JC, Tsoi KK, Leong RW, Chan FK. Upper gastrointestinal tract phenotype of Crohn's disease is associated with early surgery and further hospitalization. Inflamm Bowel Dis 2009; 15: 551-557. [PMID: 19067420 DOI:10.1002/ibd.20804]
21. Odes S, Vardi H, Friger M, Wolters F, Hoie O, Moum B, Bernklev T, Yona H, Russel M, Munkholm P, Langholz E, Riis L, Politi P, Bondini P, Tsianos E, Katsanos K, Clofent J, Vermeire S, Freitas J, Mouzas I, Limonard C, O'Morain C, Monteiro E, Fornaciari G, Vatn M, Stockbrugger R. Effect of phenotype on health care costs in Crohn's disease: A European study using the Montreal classification. J Crohns Colitis 2007; 1: 87-96. [PMID: 21172190 DOI: 10.1016/j.crohns.2007.08.004]
22. Cullen G, Donnellan F, Doherty GA, Smith M, Cheifetz AS. Evaluation of the small bowel in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2013; 7: 239-251. [PMID: 23445233 DOI: 10.1586/egh.13.11]
23. Abreu MT, Taylor KD, Lin YC, Hang T, Gaiennie J, Landers CJ, Vasiliauskas EA, Kam LY, Rojany M, Papadakis KA, Rotter JI, Targan SR, Yang H. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002; 123: 679-688. [PMID: 12198692 DOI: 10.1053/gast.2002.35393]
24. Heliö T, Halme L, Lappalainen M, Fodstad H, Paavola-Sakki P, Turunen U, Färkkilä M, Krusius T, Kontula K. CARD15/ NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut 2003; 52: 558-562. [PMID: 12631669 DOI: 10.1136/gut.52.4.558]
25. Ramadas AV, Gunesh S, Thomas GA, Williams GT, Hawthorne AB. Natural history of Crohn's disease in a populationbased cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut 2010; 59: 1200-1206. [PMID: 20650924 DOI: 10.1136/gut.2009.202101]
26. Picco MF, Zubiaurre I, Adluni M, Cangemi JR, Shelton D. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease. Am J Gastroenterol 2009; 104: 2754-2759. [PMID: 19584832 DOI: 10.1038/ajg.2009.387]
27. Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP. Long-term evolution of disease behavior of Crohn' s disease. Inflamm Bowel Dis 2002; 8: 244-250. [PMID: 12131607 DOI: 10.1097/00054725-200207000-00002]
28. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr, El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001; 49: 777-782. [PMID: 11709511 DOI: 10.1136/ gut.49.6.777]
29. Freeman HJ. Natural history and clinical behavior of Crohn' s disease extending beyond two decades. J Clin Gastroenterol 2003; 37: 216-219. [PMID: 12960719 DOI: 10.1097/00004836-200 309000-00005]
30. Freeman HJ. Temporal and geographic evolution of longstanding Crohn's disease over more than 50 years. Can J Gastroenterol 2003; 17: 696-700. [PMID: 14679418]
31. Greenstein AJ, Lachman P, Sachar DB, Springhorn J, Heimann T, Janowitz HD, Aufses AH. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988; 29: 588-592. [PMID: 3396946 DOI: 10.1136/gut.29.5.588]
32. Margagnoni G, Aratari A, Mangone M, Moretti A, Spagnolo A, Fascì Spurio F, Luchetti R, Papi C. Natural history of ileo-caecal Crohn's disease after surgical resection. A long term study. Minerva Gastroenterol Dietol 2011; 57: 335-344. [PMID: 22105722]
33. Swoger JM, Regueiro M. Evaluation for postoperative recurrence of Crohn disease. Gastroenterol Clin North Am 2012; 41: 303-314. [PMID: 22500519 DOI: 10.1016/j.gtc.2012.01.011]
34. Buisson A, Chevaux JB, Allen PB, Bommelaer G, Peyrin-Biroulet L. Review article: the natural history of postoperative Crohn' s disease recurrence. Aliment Pharmacol Ther 2012; 35: 625-633. [PMID: 22313322 DOI: 10.1111/j.1365-2036.2012.05002.x]
35. Gryboski JD, Spiro HM. Prognosis in children with Crohn's disease. Gastroenterology 1978; 74: 807-817. [PMID: 25221]
36. Harper PC, McAuliffe TL, Beeken WL. Crohn's disease in the elderly. A statistical comparison with younger patients matched for sex and duration of disease. Arch Intern Med 1986; 146: 753-755. [PMID: 3963958 DOI: 10.1001/archinte.1986.00360160189025]
37. Farmer RG, Michener WM. Prognosis of Crohn's disease with onset in childhood or adolescence. Dig Dis Sci 1979; 24: 752-757. [PMID: 487911 DOI: 10.1007/BF01317207]
38. Polito JM, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 1996; 111: 580-586. [PMID: 8780560 DOI: 10.1053/gast.1996.v111.pm8780560]
39. Weinstein TA, Levine M, Pettei MJ, Gold DM, Kessler BH, Levine JJ. Age and family history at presentation of pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2003; 37: 609-613. [PMID: 14581806 DOI: 10.1097/00005176-20031100 0-00020]
40. Freeman HJ. Age-dependent phenotypic clinical expression of Crohn's disease. J Clin Gastroenterol 2005; 39: 774-777. [PMID: 16145338 DOI: 10.1097/01.mcg.0000177243.51967.ca]
41. Freeman HJ. Comparison of longstanding pediatric-onset and adult-onset Crohn's disease. J Pediatr Gastroenterol Nutr 2004; 39: 183-186. [PMID: 15269625 DOI: 10.1097/00005176-20040800 0-00011]
42. Freeman HJ. Long-term prognosis of early-onset Crohn's disease diagnosed in childhood or adolescence. Can J Gastroenterol 2004; 18: 661-665. [PMID: 15565205]
43. Vernier-Massouille G, Balde M, Salleron J, Turck D, Dupas JL, Mouterde O, Merle V, Salomez JL, Branche J, Marti R, Lerebours E, Cortot A, Gower-Rousseau C, Colombel JF. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology 2008; 135: 1106-1113. [PMID: 18692056 DOI: 10.1053/j.gastro.2008.06.079]
44. Abraham BP, Mehta S, El-Serag HB. Natural history of pediatric-onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol 2012; 46: 581-589. [PMID: 22772738 DOI:10.1097/MCG.0b013e318247c32f]
45. Pigneur B, Seksik P, Viola S, Viala J, Beaugerie L, Girardet JP, Ruemmele FM, Cosnes J. Natural history of Crohn's disease: comparison between childhoodand adult-onset disease. Inflamm Bowel Dis 2010; 16: 953-961. [PMID: 19834970 DOI:10.1002/ibd.21152]
46. Freeman HJ. Crohn's disease initially diagnosed after age 60 years. Age Ageing 2007; 36: 587-589. [PMID: 17913760 DOI: 10.1093/ageing/afm106]
47. Charpentier C, Salleron J, Savoye G, Fumery M, Merle V, Laberenne JE, Vasseur F, Dupas JL, Cortot A, Dauchet L, Peyrin-Biroulet L, Lerebours E, Colombel JF, Gower-Rousseau C. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut 2013; Epub ahead of print. [PMID: 23408350]
48. Kugathasan S, Saubermann LJ, Smith L, Kou D, Itoh J, Binion DG, Levine AD, Blumberg RS, Fiocchi C. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease. Gut 2007; 56: 1696-1705. [PMID: 17682002 DOI: 10.1136/gut.2006.116467]
49. Dubinsky MC, Kugathasan S, Mei L, Picornell Y, Nebel J, Wrobel I, Quiros A, Silber G, Wahbeh G, Katzir L, Vasiliauskas E, Bahar R, Otley A, Mack D, Evans J, Rosh J, Hemker MO, Leleiko N, Crandall W, Langton C, Landers C, Taylor KD, Targan SR, Rotter JI, Markowitz J, Hyams J. Increased immune reactivity predicts aggressive complicating Crohn's disease in children. Clin Gastroenterol Hepatol 2008; 6: 1105-1111. [PMID: 18619921 DOI: 10.1016/j.cgh.2008.04.032]
50. Veny M, Esteller M, Ricart E, Piqué JM, Panés J, Salas A. Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients. Aliment Pharmacol Ther 2010; 31: 561-572. [PMID: 19958311 DOI: 10.1111/j.1365-2036.2009.04209.x]
51. Markowitz J, Kahn E, Daum F. Prognostic significance of epithelioid granulomas found in rectosigmoid biopsies at the initial presentation of pediatric Crohn's disease. J Pediatr Gastroenterol Nutr 1989; 9: 182-186. [PMID: 2809938 DOI: 10.1097/00005176-198908000-00009]
52. Gupta N, Cohen SA, Bostrom AG, Kirschner BS, Baldassano RN, Winter HS, Ferry GD, Smith T, Abramson O, Gold BD, Heyman MB. Risk factors for initial surgery in pediatric patients with Crohn's disease. Gastroenterology 2006; 130: 1069-1077. [PMID: 16618401 DOI: 10.1053/j.gastro.2006.02.003]
53. Kelly JK, Sutherland LR. The chronological sequence in the pathology of Crohn's disease. J Clin Gastroenterol 1988; 10: 28-33. [PMID: 3356881 DOI: 10.1097/00004836-198802000-00008]
54. Freeman HJ. Granuloma-positive Crohn's disease. Can J Gastroenterol 2007; 21: 583-587. [PMID: 17853953]
55. Meddings JB, Gibbons I. Discrimination of site-specific alterations in gastrointestinal permeability in the rat. Gastroenterology 1998; 114: 83-92. [PMID: 9428222 DOI: 10.1016/ S0016-5085(98)70636-5]
56. Camerini V, Panwala C, Kronenberg M. Regional specialization of the mucosal immune system. Intraepithelial lymphocytes of the large intestine have a different phenotype and function than those of the small intestine. J Immunol 1993; 151: 1765-1776. [PMID: 8345182]
57. Jess T, Riis L, Vind I, Winther KV, Borg S, Binder V, Langholz E, Thomsen Ø, Munkholm P. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis 2007; 13: 481-489. [PMID: 17206705 DOI: 10.1002/ibd.20036]
58. Peyrin-Biroulet L, Loftus EV, Colombel JF, Sandborn WJ. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol 2010; 105: 289-297. [PMID: 19861953 DOI: 10.1038/ajg.2009.579]
59. Lakatos PL, Golovics PA, David G, Pandur T, Erdelyi Z, Horvath A, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Veres G, Lovasz BD, Szathmari M, Kiss LS, Lakatos L. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009. Am J Gastroenterol 2012; 107: 579-588. [PMID: 22233693 DOI: 10.1038/ajg.2011.448]
60. Thomson AB, Gupta M, Freeman HJ. Use of the tumor necrosis factor-blockers for Crohn's disease. World J Gastroenterol 2012; 18: 4823-4854. [PMID: 23002356 DOI: 10.3748/wjg.v18. i35.4823]
61. Cerqueira RM, Lago PM. Clinical factors predictive of Crohn' s disease complications and surgery. Eur J Gastroenterol Hepatol 2013; 25: 129-134. [PMID: 23104203 DOI: 10.1097/ MEG.0b013e32835a7eed]
62. Orlando A, Guglielmi FW, Cottone M, Orlando E, Romano C, Sinagra E. Clinical implications of mucosal healing in the management of patients with inflammatory bowel disease. Dig Liver Dis 2013; 45: 986-991. [PMID: 23993738]